Biolife Science Overview

  • Founded
  • 2012

Founded
  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

Biolife Science General Information

Description

Imugene Ltd specializes is a clinical-stage immuno-oncology company. Its product includes HER-Vaxx, a proprietary HER2 +ve cancer vaccine that stimulates a polyclonal antibody response to HER2/neu. The company is also developing B-cell peptide cancer vaccines and therapeutics. Its only operating segment being Research, Development, and Commercialisation of oncolytic immunotherapies.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Biotechnology
Acquirer
Primary Office
  • Level 11, 66 Eagle Street
  • Brisbane, Queensland 4000
  • Australia
+61 0402 000 000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biolife Science Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 23-Oct-2013 00000 Completed Clinical Trials - Phase 3
1. Early Stage VC (Series A) 15-Dec-2012 00000 00000 Completed Startup
To view Biolife Science’s complete valuation and funding history, request access »

Biolife Science Patents

Biolife Science Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2018511659-A Vaccine composition and use thereof Active 17-Apr-2015 0000000000000
AU-2016250289-B2 A vaccine composition and uses thereof Active 17-Apr-2015 0000000000000
EP-3283105-B1 A vaccine composition and uses thereof Active 17-Apr-2015 0000000000000
US-20170119867-A1 A vaccine composition and uses thereof Active 17-Apr-2015 0000000000000
EP-3283105-A4 A vaccine composition and uses thereof Active 17-Apr-2015 A61K39/001106
To view Biolife Science’s complete patent history, request access »

Biolife Science Executive Team (1)

Name Title Board Seat Contact Info
Paul Hopper Chief Operating Officer & Director
To view Biolife Science’s complete executive team members history, request access »

Biolife Science Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Viriathus Capital Investment Bank Minority 000 0000 000000 0
To view Biolife Science’s complete investors history, request access »